Drug intelligence / Profile preview

ICTCAR-CRC

Development stage
Preclinical
Lead developer
Innovative Cellular Therapeutics
Modality
CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

ICTCAR-CRC is an autologous chimeric antigen receptor (CAR) T-cell therapy being developed by SiDanSai Biotechnology (ICT) for the treatment of colorectal cancer. The therapy utilizes the proprietary CoupledCAR® technology, which incorporates a second signaling component designed to promote the expansion and survival of CAR-T cells within the challenging immunosuppressive environment of solid tumors. ICTCAR-CRC specifically targets Guanylyl Cyclase C (GCC), a transmembrane cell surface receptor that is highly expressed in the majority of metastatic colorectal cancers but has restricted expression in normal tissues. The program is currently in the IND-enabling stage.

Other names
ICTCAR-CRC (CoupledCAR®)
02

Targets

GUCY2C (Guanylate cyclase C receptor)

Beyond the preview

Go deeper on ICTCAR-CRC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ICTCAR-CRC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call